Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+40.4%/yr
Annual compound
5Y CAGR
+79.4%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
18.6x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.12M | -4.3% |
| 2024 | $25.21M | +18.8% |
| 2023 | $21.21M | +143.6% |
| 2022 | $8.71M | +253.1% |
| 2021 | $2.47M | +90.0% |
| 2020 | $1.30M | - |